MBX Biosciences, Inc.

MBX · Nasdaq · SIC 2834: Pharmaceutical Preparations · Market Cap: $1.4B · 63 employees
33
SEC Filings
$30.65
Close 2026-06-01
63
Employees

Business Summary

PART I Item 1. B usiness. Overview We are a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel precision peptide therapies for the treatment of endocrine and metabolic disorders. Our company was founded by global leaders with a transformative approach to peptide drug design and development. Leveraging this expertise, we designed our proprietary Precision Endocrine Peptide ("PEP ") platform to overcome the key limitations of unmodified an...

Latest Stock Quote

MBX 2026-06-01 $30.65 O:$31.35 H:$32.03 L:$29.87 Vol:0.3M VWAP:$30.7388
origin leaf: 7f76a23de6456c95acc2f9dc60a50537f9e821daf0306651e39349c91a65e6eb

Next Earnings

Q2 FY2026 — expected 2026-09-14

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-122025-12-310001193125-26-103121EDGAR107K words
2025-03-172024-12-310000950170-25-039838EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-062025-09-300001193125-25-268148EDGAR24K words
2025-08-072025-06-300000950170-25-104619EDGAR—
2025-05-122025-03-310000950170-25-068602EDGAR—
2024-11-072024-09-300000950170-24-122840EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-120001193125-26-103118EDGAR3K words
2026-03-090001193125-26-097611EDGAR—
2026-02-270001193125-26-079286EDGAR—
2026-02-050001193125-26-039475EDGAR—
2026-01-220001193125-26-018700EDGAR—
2026-01-120001193125-26-009642EDGAR—
2025-11-060001193125-25-268146EDGAR—
2025-09-260001193125-25-220432EDGAR—
2025-09-220001193125-25-210049EDGAR—
2025-09-040001776111-25-000007EDGAR—

33 total filings indexed. 17 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Company Identity

CIK0001776111
TickerMBX
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE
Websitehttps://www.mbxbio.com
Listed2024-09-13

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 6ba7ea3a2517c759b6cdbdf525b7a26d9b78e094a22dd77f90ef804288c86821
parent: de29571d597dc12d1133b78b5e9695ceca9c01cc15249c008fd18d80b53af776
content hash: ae4c4372e565538ddcfaafbf60887cbb546e253cbbb03e072189cc5ac8391d71
signed: 2026-06-02T19:01:50.093Z
sources: 7 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf